Angeliki M. Tsimogianni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Angeliki M. Tsimogianni has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Anastasia Kotanidou
1st Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, Evangelismos Hospital, National and Kapodistrian University of Athens, Athens, Greece
2 shared publications Charis Roussos
Department of Critical Care and Pulmonary Services, General Hospital ‘Evangelismos’, School of Medicine, National and Kapodistrian University of Athens
2 shared publicationsEffrosyni D. Manali
2nd Pulmonary Department, ‘Attikon’ University Hospital, School of Medicine, National and Kapodistrian University of Athens
2 shared publications- Georgios T. Stathopoulos
Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Zentrum München, German Center for Lung Research (DZL), 81377 Munich, Bavaria, Germany
2 shared publications Spyros A. Papiris
2nd Pulmonary Department, ‘Attikon’ University Hospital, School of Medicine, National and Kapodistrian University of Athens
2 shared publicationsChristina Sotiropoulou
Department of Critical Care and Pulmonary Services, General Hospital ‘Evangelismos’, School of Medicine, National and Kapodistrian University of Athens
1 shared publication
Latest Publications
- 22 October 2009
- Published by Wiley in Respirology
- Vol. 14 (8) , 1114-1120
Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease
Background and objective: Although sputum culture in patients with an acute exacerbation of COPD is of uncertain value, it is routinely done. The ability to clinically identify patients likely or unlikely to yield bacterial sputum isolates would potentially reduce unnecessary tests. The objective of this study was to identify the clinical predictors of positive sputum cultures in this patient population.Methods: Consecutive patients with a COPD exacerbation requiring an emergency visit were prospectively enrolled. Quantitative sputum culture was performed on‐site. Data on current smoking, sputum purulence, FEV1, Medical Research Council chronic dyspnoea scale, BMI, severe exacerbations in the preceding year requiring hospitalization, PaO2, PaCO2, Acute Physiology and Chronic Health Evaluation (APACHE) II score, and oral and inhaled steroid use were recorded.Results: Of the 94 patients enrolled, sputum from 36 yielded bacterial pathogens. These patients were characterized by a higher frequency of purulent sputum, lower FEV1, BMI and PaO2, higher APACHE II score and more frequent use of inhaled steroids (P < 0.05). On multivariate regression, purulent sputum, FEV1 and BMI were independent determinants of a positive sputum culture. Using receiver‐operator‐optimized thresholds for these variables (purulent sputum, FEV1 < 35% predicted and BMI ≤ 22 kg/m2), we proposed a regression coefficient‐weighted prediction model that accurately determined the likelihood of sputum bacterial isolation.Conclusions: A prediction model based on the variables of purulent sputum, FEV1 and BMI predicted sputum culture result with about 90% accuracy. Pending further validation, this model may save valuable healthcare resources.
- 22 October 2009
- Published by Wiley in Respirology
- Vol. 14 (8) , 1114-1120
Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease
Background and objective: Although sputum culture in patients with an acute exacerbation of COPD is of uncertain value, it is routinely done. The ability to clinically identify patients likely or unlikely to yield bacterial sputum isolates would potentially reduce unnecessary tests. The objective of this study was to identify the clinical predictors of positive sputum cultures in this patient population.Methods: Consecutive patients with a COPD exacerbation requiring an emergency visit were prospectively enrolled. Quantitative sputum culture was performed on‐site. Data on current smoking, sputum purulence, FEV1, Medical Research Council chronic dyspnoea scale, BMI, severe exacerbations in the preceding year requiring hospitalization, PaO2, PaCO2, Acute Physiology and Chronic Health Evaluation (APACHE) II score, and oral and inhaled steroid use were recorded.Results: Of the 94 patients enrolled, sputum from 36 yielded bacterial pathogens. These patients were characterized by a higher frequency of purulent sputum, lower FEV1, BMI and PaO2, higher APACHE II score and more frequent use of inhaled steroids (P < 0.05). On multivariate regression, purulent sputum, FEV1 and BMI were independent determinants of a positive sputum culture. Using receiver‐operator‐optimized thresholds for these variables (purulent sputum, FEV1 < 35% predicted and BMI ≤ 22 kg/m2), we proposed a regression coefficient‐weighted prediction model that accurately determined the likelihood of sputum bacterial isolation.Conclusions: A prediction model based on the variables of purulent sputum, FEV1 and BMI predicted sputum culture result with about 90% accuracy. Pending further validation, this model may save valuable healthcare resources.
- Open Access
- 14 July 2009
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 24 (9) , 1043-1048
Predictors of Outcome After Exacerbation of Chronic Obstructive Pulmonary Disease
The outcome after hospitalization for an exacerbation of chronic obstructive pulmonary disease (COPD) is unfavorable and uncertainty exists about factors predicting short and long-term prognosis. To identify clinical predictors of length of hospital stay (LOS) and three-year mortality after COPD exacerbations requiring hospitalization. Retrospective analysis of prospectively collected data. All consecutive patients hospitalized with COPD exacerbation were enrolled. Disease severity was estimated by FEV1, body mass index (BMI), Medical Research Council (MRC) chronic dyspnoea scale, previous hospitalizations, need for long-term oxygen treatment (LTOT), arterial oxygen and carbon dioxide partial pressures (PaO2 and PaCO2), pH and respiratory rate. Outcome was assessed by LOS and three-year mortality. Out of 81 patients enrolled, three-year mortality data were available for 61. LOS was related to BMI, MRC scale and respiratory rate. Three-year mortality was related to FEV1, BMI, MRC scale, LTOT, and PaCO2. Multiple logistic regression analysis demonstrated that MRC scale was the only independent determinant of LOS, [p = 0.001, odds ratio (OR) 7.67 (95% CI 2.50–23.41)], whereas MRC scale and BMI predicted three-year mortality, [p = 0.001, OR 8.28 (95% CI 2.25–30.47) and p = 0.006, OR 6.91 (95% CI 1.74–27.48), respectively]. Cox regression analysis demonstrated identical results. Using receiver-operator-optimized thresholds for these variables (MRC > 2 and BMI < 25 kg/m2), we propose a prediction model that accurately determines three-year mortality risk. In this study, MRC scale and BMI predicted outcome after COPD hospitalization. Pending further validation, this predictive model may contribute to identify patients with poor outcome even when spirometric data are unavailable.
- 14 July 2009
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 24 (9) , 1043-1048
Open AccessPredictors of Outcome After Exacerbation of Chronic Obstructive Pulmonary Disease
The outcome after hospitalization for an exacerbation of chronic obstructive pulmonary disease (COPD) is unfavorable and uncertainty exists about factors predicting short and long-term prognosis. To identify clinical predictors of length of hospital stay (LOS) and three-year mortality after COPD exacerbations requiring hospitalization. Retrospective analysis of prospectively collected data. All consecutive patients hospitalized with COPD exacerbation were enrolled. Disease severity was estimated by FEV1, body mass index (BMI), Medical Research Council (MRC) chronic dyspnoea scale, previous hospitalizations, need for long-term oxygen treatment (LTOT), arterial oxygen and carbon dioxide partial pressures (PaO2 and PaCO2), pH and respiratory rate. Outcome was assessed by LOS and three-year mortality. Out of 81 patients enrolled, three-year mortality data were available for 61. LOS was related to BMI, MRC scale and respiratory rate. Three-year mortality was related to FEV1, BMI, MRC scale, LTOT, and PaCO2. Multiple logistic regression analysis demonstrated that MRC scale was the only independent determinant of LOS, [p = 0.001, odds ratio (OR) 7.67 (95% CI 2.50–23.41)], whereas MRC scale and BMI predicted three-year mortality, [p = 0.001, OR 8.28 (95% CI 2.25–30.47) and p = 0.006, OR 6.91 (95% CI 1.74–27.48), respectively]. Cox regression analysis demonstrated identical results. Using receiver-operator-optimized thresholds for these variables (MRC > 2 and BMI < 25 kg/m2), we propose a prediction model that accurately determines three-year mortality risk. In this study, MRC scale and BMI predicted outcome after COPD hospitalization. Pending further validation, this predictive model may contribute to identify patients with poor outcome even when spirometric data are unavailable.